Torsten Grigoleit
Biographic Data
| ID | 7954927 |
|---|---|
| NAME | Torsten Grigoleit |
| GIVEN NAMES | Torsten |
| FAMILY NAME | Grigoleit |
| SIGNATURE | GRIGOLEIT T |
| AFFILIATIONS | Asklepios Klinik Langen |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Novel Synthetic Opioids (NSO) Use in Opioid Dependents Entering Detoxification Treatment
NSO and also opioid analgesics did not play a relevant role in the development and the course of opioid/opioid use disorders in German patients referred for an inpatient detoxification treatment
Availability of Illegal Drugs During the Covid-19 Pandemic in Western Germany
Background: In response to the COVID-19-pandemic, a lockdown was established in the middle of March 2020 by the German Federal Government resulting in drastic reduction of private and professional traveling in and out of Germany with a reduction of social contacts in public areas. Research Questions: We seek evidence on whether the lockdown has led to a reduced availability of illegal drugs and whether subjects with substance-related problems tri…
Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
Background: Over the past 15 years, comparative assessments of psychoactive substance harms to both users and others have been compiled by addiction experts. None of these rankings however have included synthetic cannabinoids or non-opioid prescription analgesics (NOAs, e.g., gabapentinoids) despite evidence of increasing recreational use. We present here an updated assessment by German addiction medicine experts, considering changing Western con…
No prominent works on this page.
Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
Background: Over the past 15 years, comparative assessments of psychoactive substance harms to both users and others have been compiled by addiction experts. None of these rankings however have included synthetic cannabinoids or non-opioid prescription analgesics (NOAs, e.g., gabapentinoids) despite evidence of increasing recreational use. We present here an updated assessment by German addiction medicine experts, considering changing Western con…
Availability of Illegal Drugs During the Covid-19 Pandemic in Western Germany
Background: In response to the COVID-19-pandemic, a lockdown was established in the middle of March 2020 by the German Federal Government resulting in drastic reduction of private and professional traveling in and out of Germany with a reduction of social contacts in public areas. Research Questions: We seek evidence on whether the lockdown has led to a reduced availability of illegal drugs and whether subjects with substance-related problems tri…
Novel Synthetic Opioids (NSO) Use in Opioid Dependents Entering Detoxification Treatment
NSO and also opioid analgesics did not play a relevant role in the development and the course of opioid/opioid use disorders in German patients referred for an inpatient detoxification treatment
Drug (3 works) · Heroin (3 works) · Medicine (3 works) · Opioid Use Disorder Treatment (3 works) · Psychiatry (3 works) · Cannabinoid (2 works) · Cannabis (2 works) · Opioid (2 works) · Psychoactive drug (2 works) · Synthetic cannabinoids (2 works)